361 related articles for article (PubMed ID: 12622871)
1. Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease.
Boitier E; Gautier JC; Roberts R
Comp Hepatol; 2003 Jan; 2(1):3. PubMed ID: 12622871
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Marx N; Duez H; Fruchart JC; Staels B
Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptors and the control of inflammation.
Cabrero A; Laguna JC; Vázquez M
Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
5. The Role of PPARs in Disease.
Wagner N; Wagner KD
Cells; 2020 Oct; 9(11):. PubMed ID: 33126411
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Chinetti G; Fruchart JC; Staels B
Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
[TBL] [Abstract][Full Text] [Related]
7. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.
Bility MT; Thompson JT; McKee RH; David RM; Butala JH; Vanden Heuvel JP; Peters JM
Toxicol Sci; 2004 Nov; 82(1):170-82. PubMed ID: 15310864
[TBL] [Abstract][Full Text] [Related]
8. PPAR: a mediator of peroxisome proliferator action.
Green S
Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
[TBL] [Abstract][Full Text] [Related]
9. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
[TBL] [Abstract][Full Text] [Related]
10. [Development of a cell-based peroxisome proliferator-activated receptors (PPARs) screening model and its application for evaluation of triterpenoids isolate from Alismatis Rhizoma].
Li XY; Wang XH; Huang XQ; Wu TT; Xu W; Wu SS
Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(21):4015-4022. PubMed ID: 28929690
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
Yessoufou A; Wahli W
Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.
Guan Y; Breyer MD
Kidney Int; 2001 Jul; 60(1):14-30. PubMed ID: 11422732
[TBL] [Abstract][Full Text] [Related]
13. PPARs and angiogenesis.
Bishop-Bailey D
Biochem Soc Trans; 2011 Dec; 39(6):1601-5. PubMed ID: 22103494
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptors (PPARs): from metabolic control to epidermal wound healing.
Wahli W
Swiss Med Wkly; 2002 Feb; 132(7-8):83-91. PubMed ID: 11971202
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors and inflammation.
Moraes LA; Piqueras L; Bishop-Bailey D
Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
[TBL] [Abstract][Full Text] [Related]
16. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
Alemán G; Torres N; Tovar AR
Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
Aleshin S; Strokin M; Sergeeva M; Reiser G
Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
19. Involvement of PPARα and PPARγ in apoptosis and proliferation of human hepatocarcinoma HepG2 cells.
Maggiora M; Oraldi M; Muzio G; Canuto RA
Cell Biochem Funct; 2010 Oct; 28(7):571-7. PubMed ID: 20862655
[TBL] [Abstract][Full Text] [Related]
20. [PPARs, metabolic syndrome and cardiac diseases].
Carvajal K; Hernández-Esquivel Mde L; Moreno-Sánchez R
Arch Cardiol Mex; 2007; 77 Suppl 4():S4-66-76. PubMed ID: 18938701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
